For example, inhibition of PU.1 has been shown to ameliorate metabolic dysfunction and non‐alcoholic hepatitis by reducing fibrosis,25 PU.1 has been associated with hepatitis C virus–mediated induction of inflammatory responses and fibrosis 65 and promotes hepatic fibrosis via activation of the hepatocytes.28 Here, SPI1 is linked to Hepatic fibrosis.